Samedi 26 septembre 2020 - 02:03 | A ne pas manquer : Le 10 Septembre 2020 - Réunion de la Banque centrale européenne



Présentation de la société
LeGuideBoursier.com

Description de la société pas encore définie

Leading surgeons highlight nitinol compression anastomosis at the 130th german congress for surgery (dgch)

  • Publié le Lundi 13 mai 2013 à 11:10
  • Catégorie : ,
  • Source : Actusnews

Regional Experience Substantiates Positive Global Data for novoGI(TM) ColonRing
ATLANTA, May 13, 2013 (GLOBE NEWSWIRE) -- novoGI Inc. today announced the success of a scientific symposium on novoGI's nitinol compression anastomosis in Munich at the 130th Kongress der Deutschen Gesellschaft für Chirurgie (DGCH), The German Congress for Surgery. DGCH is the largest German surgical meeting, with over 8000 participants mainly from Germany, Switzerland, and Austria and other regions.

At DGCH, the Satellite Symposium Die Anastomose bei der Tiefen Anterioren Resektion mit dem ColonRing [Anastomoses in Low Anterior Resection with ColonRing] included podium presentations by leading surgeons. The session focused on clinical experience in surgical practice as well as published data covering successful outcomes for novoGI™ ColonRing in terms of low leak rates of and healing processes for low anterior resection (LAR) procedures.

Clinical presentations included:

  • Common Types of Anastomosis on the Colon and the ColonRing as a New Alternative (ID: 2102) presented by Prof Paul-Antoine Lehur, MD (CHU de Nantes, Nantes, France).
  • Kompressionsanastomose mit ColonRing Was Sagen die Daten? [Compression Anastomosis with ColonRing What Does the Data Say?] (ID 2103) presented by Prof Oliver Schwandner, MD (KH by Barmherzige Brüder, Regensburg, Germany).
  • Low Anterior Resection Anastomosis (LARA) - Personal Experience and Management of Complications (ID 2104) presented by Prof Friedrich Herbst, MD, FRCS, (KH Barmherzige Brüder, Vienna, Austria) who has performed over 200 compression anastomosis procedures.

The presentations were followed by panel discussion moderated by Asad Kutup, MD on behalf of Prof Jakob R. Izbicki, FACS, FRCS, Ed. Hon. (University of Hamburg, Hamburg, Germany).

"The depth of presentations and level of interest in compression anastomosis with the novoGI™ ColonRing device at scientific meetings worldwide in recent weeks - at the American Society of Colon & Rectal Surgeons (ASCRS) Annual Meeting in the USA, DGCH in Germany, and major congresses in France - underscore the importance and growing global acceptance of our clinically proven technology for improving patient care," noted Gavriel D. Meron, novoGI President and Chief Executive Officer. "The increased involvement of leading surgeons worldwide demonstrated at the 2nd Annual Meeting of the World Congress of Compression Anastomosis (WCCA) held recently in Phoenix, Arizona is continuing to drive educational and research activities in this field."

About novoGI
novoGI
is focused on providing an expanding range of solutions for GI disease management through a globally branded, high quality, market driven company. The US headquarters are in Atlanta, Georgia; research, development and manufacturing facilities in Netanya, Israel; and its European headquarters are near Paris, France. The company's website is www.novoGI.com.

NOVOGI, the NOVOGI logo, the GI logo, and DEFINING THE FUTURE are trademarks and/or registered trademarks of novoGI Inc.

CONTACT: [email protected]
www.novoGI.com


Information non réglementée

Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-32005-Leading-Surgeons-Highlight-Nitinol-Compression-Anastomosis-at-the-130th-German-Congress-for-Surgery.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Article précédent

Acanthe Developpement : Communiqué sur les résultats semestriels au 30 juin 2020

Ce contenu est diffusé par Hugin, il n`a qu`une portée informative et pédagogique.Les informations et données financières ainsi que les analyses diffusées par Hugin n`ont aucune valeur contractuelle et ne constituent en aucun cas une aide à la décision, une offre de vente ou une sollicitation d`achat de valeurs mobilières ou d`instruments financiers.

La responsabilité de LeGuideBoursier.com et/ou de ses dirigeants et salariés ne peut être retenue directement ou indirectement suite à l`utilisation des informations et analyses par les lecteurs et sur la pertinence des informations diffusées.

Il est recommandé à toute personne non avertie de consulter un conseiller professionnel avant tout investissement, car le trading peut vous exposer à des pertes supérieures aux dépôts chez votre broker.

Tout investisseur doit se faire son propre jugement avant d`investir dans un produit financier afin qu`il soit adapté à sa situation financière, fiscale et légale

Vous aimerez aussi